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a b s t r a c t
Introduction: Burns cause physiologic changes in multiple organ systems in the body. Burn
mortality is usually attributable to pulmonary complications, which can occur in up to 41% of
patients admitted to the hospital after burn. Patients with preexisting comorbidities such as
chronic lung diseases may be more susceptible. We therefore sought to examine the impact
of preexisting respiratory disease on burn outcomes.
Methods: A retrospective analysis of patients admitted to a regional burn center from 2002–
2012. Independent variables analyzed included basic demographics, burn mechanism,
presence of inhalation injury, TBSA, pre-existing comorbidities, smoker status, length of
hospital stay, and days of mechanical ventilation. Bivariate analysis was performed and Cox
regression modeling using significant variables was utilized to estimate hazard of
progression to mechanical ventilation and mortality.
Results: There were a total of 7640 patients over the study period. Overall survival rate was
96%. 8% (n=672) had a preexisting respiratory disease. Chronic lung disease patients had a
higher mortality rate (7%) compared to those without lung disease (4%, p<0.01). The adjusted
Cox regression model to estimate the hazard of progression to mechanical ventilation in
patients with respiratory disease was 21% higher compared to those without respiratory
disease (HR=1.21, 95% CI=1.01–1.44). The hazard of progression to mortality is 56% higher
(HR=1.56, 95% CI=1.10–2.19) for patients with pre-existing respiratory disease compared to
those without respiratory disease after controlling for patient demographics and injury
characteristics.
Conclusion: Preexisting chronic respiratory disease significantly increases the hazard of
progression to mechanical ventilation and mortality in patients following burn. Given the
increasing number of Americans with chronic respiratory diseases, there will likely be a
greater number of individuals at risk for worse outcomes following burn.
a r t i c l e i n f o
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Burn results is significant morbidity and mortality worldwide.
In the United States, an estimated 486,000 burns occurred in
2015 [1]. Following major burns, mortality is usually attribut-
able to pulmonary complications, which can occur in up to 41%
of patients admitted to the hospital after burn [2–4]. Previous
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studies over the last three decades have shown the effect of
burns on the respiratory system occurs in three phases [5–9].
These three phases are the early or resuscitative phase (first
48h), the post-resuscitative phage (2–7 days), and the late
phase (beyond 7 days) after burn. Phase I is seen within
minutes to hours as acute respiratory distress secondary to
thermal injury from smoke inhalation, carbon monoxide
poisoning, or secondary to airway obstruction. Pulmonary
edema that occurs is seen as precursor to the development of
ARDS in burn. The Phase II includes patients that were
asymptomatic for the initial 24–48h; however, develop
symptoms of tachypnea and hypoxemia within 5days after
burn. Patients develop atelectasis, acute respiratory distress
Syndrome (ARDS), analgesic related respiratory suppression,
or ventilatory failure. Lastly, phase III develop late complica-
tions such as pneumonia and pulmonary emboli [8,9].
With increase in longevity of the US population, there is a
concomitant rise in the number of people with health related
comorbidities, particularly chronic respiratory diseases. There
is a broad spectrum of respiratory diseases but they can be
broadly classified as either obstructive or restrictive respira-
tory disease [10]. Examples of obstructive lung diseases
include chronic bronchitis and emphysema, asthma, cystic
fibrosis, and bronchiectasis. In contrast, restrictive lung
diseases such as sarcoidosis, interstitial lung disease, pulmo-
nary fibrosis, hypoventilation syndrome due to obesity, and
amyotrophic lateral sclerosis are characterized by reduce lung
volume making it difficult to fully expand to fill lungs with air
[10].
Current burn mortality prediction models such as the Baux
score utilize age, % total body surface area (TBSA) of burn, and
presence of inhalation injury but do not account for pre-
existing comorbidities such as respiratory diseases. The
contribution of pre-existing chronic respiratory diseases
(PCRD) on burn outcomes is currently undefined. We hypoth-
esize that patients with PCRD will have an increased
progression to mechanical ventilation and mortality following
burn.
2. Methods
This is a retrospective study of all burn patients admitted to the
University of North Carolina Jaycee Burn Center from 2001 to
2012. The North Carolina Jaycee Burn Center at UNC was
established in 1981 and averages more than 1200 acute
admissions per year. The burn center is a single unit, 36-bed
facility that has been verified by the American Burn Associa-
tion for pediatric and adult care.
The medical records of subjects identified by the UNC Burn
database query were reviewed to verify baseline demographic
data, injury characteristics, and provide detailed information
on medical comorbidities. Pre-existing comorbidities was
obtained from information reported by patient, family, or
others that intimately know the patient’s history upon
admission to the burn center. This are entered into the
medical records. Subsequently, two dedicated burn registry
nurses that collect, review and validate this data, enter the
data into the University of North Carolina Burn Registry. The
burn registry data is then uploaded to the National Trauma
Data bank (NTDB) of the American College of Surgeons. It
includes 27 different preinjury comorbidities. Smoking status
for all the patients in the database was also recorded. Injury
characteristics of interest included burn etiology, %TBSA burn,
presence of inhalation injury, and intubation status on
admission to the burn center. Inhalation injury diagnosis
was based on history, physical examination, and/or broncho-
scopic examination. The number of days on mechanical
ventilation in the intensive care unit was included. All patients
in the ICU were treated with the prevailing standard of care
(i.e., ventilator management, fluid resuscitation, etc.) at a large
academic burn center at the time of admission
To examine the effect of baseline medical comorbidities on
outcome, a Charlson Comorbidity Index (CCI) score was
calculated for each patient. The standardized Charlson Index
has been reported to accurately predict the probability of
mortality within 1year for a number of medical conditions
[11,12]. The score is the weighted sum of comorbid conditions.
There are 17 comorbid conditions included in the score and
each is assigned a weight from 1 to 6 points. The weighted sum
of all comorbid conditions is the patient’s Charlson score
(Table 1). The CCI was also modified for this study to exclude
respiratory disease to elicit the independent effect of respira-
tory disease on burn outcome. By removing pre-existing
respiratory diseases from the CCI, we avoid controlling twice
for respiratory disease in our cox proportional statistical
analysis, as chronic respiratory disease was a separate
independent variable. We validated the modified CCI by
comparing the predictive probability of mortality of CCI with
the mCCI and there was no statistical significant differences
noted, as both were equally predictive (Supplementary
material Figs. 1 and 2).
The outcomes of interest in this study included in-hospital
mortality and need for mechanical ventilation. Patients who
had withdrawal of care were included in the analysis as they
Table 1 – Charlson Comorbidity Index score system.
Comorbidity Score
Myocardial infarction 1
Congestive heart failure 1
Peripheral vascular disease 1
Cerebrovascular disease 1
Dementia 1
Chronic pulmonary disease 1
Rheumatologic disease 1
Peptic ulcer disease 1
Mild liver disease 1
Diabetes without chronic complications 1
Diabetes with chronic complications 2
Hemiplegia or paraplegia 2
Renal disease 2
Any malignancy, including leukemia and lymphoma 2
Moderate or severe liver disease 3
AIDS/HIV 6
Metastatic solid tumor 6
Maximum comorbidity score 33
were admitted to the burn center. Older age (>70years) and/or
greater than 75% TBSA burn triggered a discussion with family
on withdrawal care. The number of patients who had care
withdrawn was small and not statistically significantly
different in patients with or without PCRD.
Baseline patient and injury characteristics were compared
between groups (Lived/Died) using Analysis of Variance for
continuous variables and chi-squared for discrete variables. We
employed both univariate and multivariate models to deter-
mine the relative influence of PCRD after controlling for
covariates.Toestimate the hazardofprogression to mechanical
ventilationandmortality,weused a multivariate cox regression
model controlling for pertinent confounders (age, TBSA,
mechanism of injury, presence of inhalation injury, comorbid-
ities using CCI, and smoker status). Stata/MP (Version 12)
(Statacorp, College Station, TX) was used for all data manage-
ment and statistical analysis. The University of North Carolina
Institutional Review Board approved this study.
3. Results
A total of 7640 patients were admitted during the study period
and included in our analysis. The mean age was 3222years
with a male predominance at 5244 (68%). Caucasians made up
3896 (51%) of the population. The most common burn
mechanism was scald (n=3687, 49%) followed by flame injury
(n=3453, 45%). The overall mean %TBSA for this population
was 8.612% (Table 2). There was no significant difference in %
TBSA based on race or sex. The mean hospital/ICU length of
stay, and days of mechanical ventilation was 12.724.7 days,
5.120.2 days, and 3.215.8days respectively (p<0.001). Burn
patients with at least one comorbidity represented 40% of the
population (n=3057). A total of 672 patients had pre-existing
respiratory disease prior to burn. Chronic preexisting respira-
tory diseases included in this study were COPD (n=236, 35%),
chronic bronchitis (n=43, 6%), emphysema (n=31, 5%), asthma
(n=297, 44%), obstructive sleep apnea (n=68, 10%), sarcoidosis
(n=8, 1%) and other (n=12, 2%). Concurrent smokers were 18%
of burn cohort (n=1347).
3.1. Respiratory disease
A bivariate analysis was performed to compare patients with
preexisting respiratory disease (PCRD) and without preexisting
respiratory disease (NRD). The mean age for PCRD vs. NRD was
42.524.7years and 30.921.9years, respectively (p<0.001).
There was a significant difference between the two groups
with race and sex (p<0.001) but no difference was seen in %
TBSA. PCRD patients had a higher modified CCI score (0.80
1.40) compared to NRD patients (0.300.86, p<0.001).
Percentage of smokers for PCRD vs. NRD was 32% and 16%,
respectively (p<0.001). Inhalation injury was higher in PCRD
patients compared to NRD patients (15% vs. 7%, p<0.001). The
crude mortality rate was higher for patients with PCRD (7% vs.
4%, p<0.001). Patients with PCRD had statistically significant
increase in hospital-LOS (17.929.5days vs. 12.124.0 days,
p<0.001) and ICU-LOS stay (9.022.7days vs. 4.719.9 days,
p<0.001), and ventilator days (6.2days vs. 2.9 days, p<0.001)
compared to NRD patients (Table 3).
A multivariate Cox regression model was utilized to
determine increased hazard of progression to mechanical
ventilation and mortality in the PCRD vs. NRD subgroups after
adjusting for significant covariates on bivariate analysis. The
estimated increased hazard of progression to mechanical
ventilation was 21% higher (HR=1.21, 95% CI=1.01–1.44) for
patients with PCRD compared to those without disease (Table 4
and Fig. 1). The estimated increased hazard of progression to
mortality is 56% higher (HR=1.56 (NRD reference group), 95%
confidence interval: 1.10–2.19) for patients with PCRD com-
pared to NRD (Table 5). There is a continuous significant
difference in mortality between the two groups starting at
60days after adjusted the Kaplan Meier survival curve for
significant covariates (p<0.01, Fig. 2).
4. Discussion
In this study, we have shown that burn patient with
preexisting chronic respiratory comorbidities have an
Table 2 – Patient characteristics.














Inhalation injury 562 7%
No inhalation injury 7,078 93%
Charlson Comorbidity Index (CCI)
Overall mean 7,640 0.906864 (1.4)
40%
TBSA
Overall mean 7,640 8.6 (12.0)
By sex
Male 5,244 9.0 (12.6)










Overall mean 5.1 (20.2)
Hospital stay
Overall mean 12.7 (24.7)
Mechanical ventilation
Overall mean 956 3.2 (15.8)
TBSA=total burn surface area.
increased estimated hazard of progression to mechanical
ventilation and mortality compared to burn patients without
pre-existing respiratory diseases after controlling for signifi-
cant covariates. Furthermore, outcomes such as length of
hospital/ICU stay and days on mechanical ventilation were
significantly longer for patients who presented with a
preexisting respiratory disease.
These findings are particularly relevant as some respiratory
diseases are associated with increased risk of burn. Individuals
with COPD on home oxygen are at increased risk of burn [12–
14]. Sharma et al. found that the absolute risk of burn in
patients prescribed oxygen therapy was 2.98 per 1000 patients
compared with 1.69 per 1000 patients not prescribed oxygen
during a 22-month period [15].
The only prior study evaluating the impact of preexisting
comorbidities, including respiratory disease on in-hospital
burn mortality utilized the National Burn Repository (NBR) on
31,338 burn records from 1995–2005. Though they showed that
there was a significant increase crude mortality rate in
patients with chronic pulmonary disease (14.3% vs. 6.6%,
p<0.001) compared to those without chronic pulmonary
disease, contrary to our findings, chronic pulmonary disease
was not significant independent predictor of mortality but
there was a trend toward greater risk of mortality as these
patients tended to have additional medical comorbidities that
may diminish its effect. Furthermore, similar to our study,
hospital length of stay was longer (15.9 vs. 12.9, p<0.001) in
Table 3 – Bivariate analysis of burn patients (with and without preexisting respiratory disease).
Respiratory disease No respiratory disease p-Value
Age 42.5 (24.7) 30.9 (21.9) <0.001
TBSA 8.4 (11.6) 8.6 (12.1) 0.789












Smoker 32% 16% <0.001
Non-smoker 68% 84%
Inhalation injury 15% 7% <0.001
Mortality rate 7% 4% <0.001
ICU stay 9.0 (22.7) 4.7 (19.9) <0.001
LOS 17.9 (29.5) 12.1 (24.0) <0.001
Mechanical ventilation 6.2 (19.2) 2.9 (15.4) <0.001
TBSA=total body surface area.
mCCI=Charlson Comorbidity Index excluding preexisting respiratory diseases.
Table 4 – Multivariate Cox regression for mechanical ventilation in burn cohort.
Variable Adjusted hazard ratio, 95% confidence interval (CI) p-Value
Age 1.00 (0.99–1.00) 0.947
TBSA 0.99 (0.98–0.99) <0.001
Mechanism
Flame (reference group)
Scald 0.74 (0.60–0.92) 0.005
Other 1.04 (0.78–1.38) 0.792
mCCI 0.91 (0.85–0.97) 0.002
Inhalation injury 1.36 (1.18–1.56) <0.001
Smoker status 0.81 (0.68–0.96) 0.017
Respiratory disease 1.21 (1.01–1.44) 0.037
TBSA=total body surface area.
mCCI=Charlson Comorbidity Index excluding respiratory diseases.
those with chronic pulmonary disease compared to patients
without [16].
Majority of patients included in our study had preexisting
obstructive pulmonary disease. The association between
thermal burns and respiratory insufficiency is well estab-
lished. There are several different mechanisms in the
pathogenesis of the pulmonary complications that may be
more pronounced on patients with preexisting respiratory
disease and some these are time dependent. It is well known
that direct heat injury to the lungs is not a major cause of lung
injury in burn patients as direct burn to the respiratory tract
below the larynx is unusual [17], however, the products of
combustion are toxic to the airways and result in broncho-
spasm coupled with a diminished mucociliary clearance in the
presence of preexisting obstructive airway disease may
contribute to the increased mortality [18].
In burn patients with preexisting chronic respiratory
disease, any associated decreased chest wall movements
secondary to eschar, pain, narcotic use and altered mental
status will result in shallow breathing and gradual alveolar
collapse, decreased functional residual capacity and ultimate-
ly decreased lung compliance and shunting [19,20]. Further-
more, depending on the burn size and presence of inhalation
injury, toxin induced chemical pulmonary edema and lack of a
balanced fluid resuscitation approach may lead to increased
lung water [21].
Lastly, Infectious complications are a constant threat to
thermally injured patients during hospitalizations and are a
Fig. 1 – Adjusted Kaplan Meier curve for progression to mechanical ventilation comparing burn patients with and without pre-
existing respiratory disease.
Table 5 – Multivariate Cox regression for mortality in burn cohort.
Variable Adjusted hazard ratio, 95% confidence interval (CI) p-Value
Age 1.05 (1.05–1.06) <0.001
TBSA 1.06 (1.06–1.07) <0.001
Mechanism
Flame (reference group)
Scald 0.54 (0.36–0.81) 0.003
Other 0.99 (0.50–1.96) 0.970
Mechanical ventilation 1.03 (1.02–1.04) <0.001
ICU LOS 0.95 (0.94–0.96) <0.001
mCCI 1.18 (1.09–1.28) <0.001
Inhalation injury 1.95 (1.49–2.56) <0.001
Smoker status 0.63 (0.44–0.91) 0.014
Respiratory disease 1.56 (1.10–2.19) 0.011
TBSA=total body surface area.
ICU LOS=intensive care unit length of stay.
mCCI=Charlson Comorbidity Index excluding respiratory diseases.
predominant cause of death. Most of the infections that
develop in burn patients are nosocomial and of a pulmonary
etiology. The etio-pathogenesis of pneumonia in a burn
patient is multifactorial. Severely burned patients who require
mechanical ventilation with or without inhalation injury have
an increased pneumonia rates because of serious immuno-
suppression after the burn trauma [22]. Also, aspiration of
contaminated oropharyngeal secretions is the first step in the
pathogenesis of lower airways infections. S. pneumoniae, H.
influenzae, and S. aureus are the classic community-acquired
bacteria carried in the oropharynx of previously healthy
individuals. They are the microorganisms involved in primary
endogenous pneumonia [23]. Bacteria that most commonly
cause ventilator-associated pneumonia is Pseudomonas aeru-
ginosa with a prevalence of 4% [24] and mortality rate of 13.5%
despite appropriate antibiotics [25]. Known risk factors for P.
aeruginosa infections are prior antibiotic exposures and
duration on mechanical ventilation greater than 5 days [26].
Patients with pre-existing respiratory diseases are certainly
more susceptible to pneumonia. Previous studies have found
the in-hospital mortality rate to be between 20–30% for patients
requiring mechanical ventilation for COPD exacerbation [27–
30]. In addition, patients with COPD have been found to have
high neutrophil, macrophages, and CD8+ T cells in the lungs.
This creates an imbalance of pro-inflammatory and protective
mediators normally found in healthy individuals as these cells
release inflammatory cytokines and proteases [31–33]. Ob-
structive lung disease that develop with increasing age and the
additive effect on immune system dysfunction in older
individuals with preexisting chronic respiratory disease may
be partly responsible for the increase susceptibility to
pulmonary infections and/or increase mortality following
burn.
The increased hazard for mortality cannot be attributed to
mechanical ventilation alone and there has to be additional
mechanism for the increased hazard for mortality in patients
with PRCD. We postulate that in this patient population, the
increased pathology of the underlying chronic respiratory
disease e.g., Sarcoidosis or COPD and indeed the necessary
therapeutic strategies e.g., chronic steroid use within the burn
milieu are contributory. Furthermore, frailty is an important
component in these patient that may be additive.
Strategies to mitigate the poor outcomes in the subset of
burn patients with preexisting respiratory disease should be
based on maximal medical therapy of the underlying respira-
tory disease. Additional steps include reducing pulmonary
complications of burn and therapy. Close attention to prevent-
ing airway obstructions secondary to edema, sloughed mucosa
and bronchospasm is essential. Preventing pulmonary edema
with a balanced resuscitation strategy aimed at guaranteeing
stable macro- and micro-hemodynamics, while avoiding
excessive interstitial fluid overload is especially important in
these patients. This can be achieved using a goal directed
resuscitation strategy that utilizes both clinical variables such
as vital signs, mean arterial pressure, urine output and
hemodynamicmonitoringadjuncts thatcombinepulsecontour
analysis and trans-pulmonary thermodilution technique. Also
transthoracic/esophageal echocardiogram can help guide
volume status [34]. For intubated patients, frequent endotra-
cheal suctioning and therapeutic bronchoscopy may be neces-
sary as is the use of bronchodilators. Preventing atelectasis with
lung recruitment maneuvers is often necessary. Prevention of
ventilator associated pneumonia and culture guided use of
antibiotics must be instituted early.
The limitations of this study are those inherent to any study
with a retrospective methodology. Though this is a single
Fig. 2 – Adjusted Kaplan Meier survival curve comparing burn patients with and without pre-existing respiratory disease.
center study, our sample size was robust enough not to affect
the generalizability of our findings. The pre-existing comor-
bidities were abstracted from documented diagnosed based on
ICD-9 codes and hence subject to interpretation. The contri-
bution of frailty and its effect on to outcome was not evaluated.
All respiratory diseases were groups were categorized as one
entity and the individual contribution of each individual
respiratory diseases and its weight on burn mortality was not
analyzed. Lastly, we acknowledge that over the study period,
ventilatory management has evolved with low tidal strategies
and targeted use of neuromuscular blockade and we cannot
entirely control for these variables. Dichotomization of our
dataset into two time periods 2001–2009 and 2010–2012 did not
diminish the independent effect of preexisting chronic
respiratory disease on burn mortality
5. Conclusion
Preexisting chronic respiratory disease significantly increases
the hazard of progression to mechanical ventilation and
mortality in patients following burn. These findings re-
emphasizes the need for the inclusion of comorbidities in
any burn mortality prediction models so as to better inform
burn mortality prognostication. Given the increasing number
of Americans with acute or chronic respiratory diseases, there
will likely be a greater number of individuals at risk for worse
outcomes following burn.
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